Xylem Q2 Adj. EPS $1.46 Beats $1.34 Estimate, Sales $2.336B Miss $2.341B Estimate
Share
Why It Matters
Xylem made more profit per share than people expected, which is good. But they sold slightly less stuff than people thought they would, which is a tiny disappointment.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.